3 ms·

That was a very interesting video. Why was the AuviQ withdrawn?

7Z7 10y ago
Bridgewater, NJ - Sanofi US is voluntarily recalling all Auvi-Q® (epinephrine injection, USP). The recall involves all Auvi-Q currently on the market and includes both the 0.15 mg and 0.3 mg strengths for hospitals, retailers and consumers. This includes lot numbers 2081278 through 3037230, which expire October 2015 through December 2016.The products have been found to potentially have inaccurate dosage delivery, which may include failure to deliver drug. http://www.fda.gov/Safety/Recalls/ucm469980.htm http://www.fda.gov/Safety/Recalls/ucm469980.htm
- gravypod 10y ago
  > which may include failure to deliver drug The way this sounds it's not mechanical but a software bug. How interesting. I'd love it if someone did some RE on these and found their failure mode.
  - untog 10y ago
    > The way this sounds it's not mechanical but a software bug. To me that sounds very much like a mechanical bug - the delivery mechanism failed. How much software do these things have in them, anyway?
    - AtheistOfFail 10y ago
      > How much software do these things have in them, anyway? Any answer other than "fucking zero" would be terrifying. I'm not risking my life on some guy properly writing a software module (says the guy driving a car to work this morning)
    - gravypod 10y ago
      Watch the video and you'll see. The thing has a lot of scripted audio files and seems like it has a beefy battery.
ci5er 10y ago
Quality Control issues. There's an interesting post about the whole Epipen fiasco here: - http://slatestarcodex.com/2016/08/29/reverse-voxsplaining-drugs-vs-chairs/ http://slatestarcodex.com/2016/08/29/reverse-voxsplaining-dr... The author's first comment (the first response to the first comment) is (to me) also interesting...
- maxerickson 10y ago
  That's kind of a fun juxtaposition there. A product withdrawn because it didn't work and a rant about complex regulation of products that consumers expect to be 100% reliable.
  - Symmetry 10y ago
    And the FDA was right to withdraw it. But the only reason it was around in the first place was that it was a sophisticated but also relatively complicated improvement on the EpiPen. It's Europe's 8 different brands that are basically just as simple as an EpiPen that the author really wants in the US.

7Z7 10y ago

Bridgewater, NJ - Sanofi US is voluntarily recalling all Auvi-Q® (epinephrine injection, USP). The recall involves all Auvi-Q currently on the market and includes both the 0.15 mg and 0.3 mg strengths for hospitals, retailers and consumers. This includes lot numbers 2081278 through 3037230, which expire October 2015 through December 2016.The products have been found to potentially have inaccurate dosage delivery, which may include failure to deliver drug. http://www.fda.gov/Safety/Recalls/ucm469980.htm http://www.fda.gov/Safety/Recalls/ucm469980.htm

gravypod 10y ago
> which may include failure to deliver drug The way this sounds it's not mechanical but a software bug. How interesting. I'd love it if someone did some RE on these and found their failure mode.
- untog 10y ago
  > The way this sounds it's not mechanical but a software bug. To me that sounds very much like a mechanical bug - the delivery mechanism failed. How much software do these things have in them, anyway?
  - AtheistOfFail 10y ago
    > How much software do these things have in them, anyway? Any answer other than "fucking zero" would be terrifying. I'm not risking my life on some guy properly writing a software module (says the guy driving a car to work this morning)
  - gravypod 10y ago
    Watch the video and you'll see. The thing has a lot of scripted audio files and seems like it has a beefy battery.

ci5er 10y ago

Quality Control issues. There's an interesting post about the whole Epipen fiasco here: - http://slatestarcodex.com/2016/08/29/reverse-voxsplaining-drugs-vs-chairs/ http://slatestarcodex.com/2016/08/29/reverse-voxsplaining-dr... The author's first comment (the first response to the first comment) is (to me) also interesting...

maxerickson 10y ago
That's kind of a fun juxtaposition there. A product withdrawn because it didn't work and a rant about complex regulation of products that consumers expect to be 100% reliable.
- Symmetry 10y ago
  And the FDA was right to withdraw it. But the only reason it was around in the first place was that it was a sophisticated but also relatively complicated improvement on the EpiPen. It's Europe's 8 different brands that are basically just as simple as an EpiPen that the author really wants in the US.